[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EP2753363A4 - Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires - Google Patents

Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires

Info

Publication number
EP2753363A4
EP2753363A4 EP12829354.5A EP12829354A EP2753363A4 EP 2753363 A4 EP2753363 A4 EP 2753363A4 EP 12829354 A EP12829354 A EP 12829354A EP 2753363 A4 EP2753363 A4 EP 2753363A4
Authority
EP
European Patent Office
Prior art keywords
compositions
treating
methods
preventing injuries
respiratory level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP12829354.5A
Other languages
German (de)
English (en)
Other versions
EP2753363A2 (fr
Inventor
Jianjie Ma
Noah Weisleder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rutgers State University of New Jersey
Rutgers Biomedical and Health Sciences
Original Assignee
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Medicine and Dentistry of New Jersey, Rutgers State University of New Jersey filed Critical University of Medicine and Dentistry of New Jersey
Publication of EP2753363A2 publication Critical patent/EP2753363A2/fr
Publication of EP2753363A4 publication Critical patent/EP2753363A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP12829354.5A 2011-09-07 2012-09-06 Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires Withdrawn EP2753363A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161531708P 2011-09-07 2011-09-07
PCT/US2012/053920 WO2013036610A2 (fr) 2011-09-07 2012-09-06 Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires

Publications (2)

Publication Number Publication Date
EP2753363A2 EP2753363A2 (fr) 2014-07-16
EP2753363A4 true EP2753363A4 (fr) 2015-03-11

Family

ID=47832768

Family Applications (1)

Application Number Title Priority Date Filing Date
EP12829354.5A Withdrawn EP2753363A4 (fr) 2011-09-07 2012-09-06 Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires

Country Status (3)

Country Link
EP (1) EP2753363A4 (fr)
CN (1) CN104066452A (fr)
WO (1) WO2013036610A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112940098A (zh) * 2016-04-06 2021-06-11 牡丹江友搏药业有限责任公司 一种mg53突变体及其制备方法和应用
KR102483242B1 (ko) 2016-08-01 2022-12-29 호프 메디신 (난징) 씨오., 엘티디. Mg53 돌연변이체, 및 그의 제조 방법 및 그의 용도
CN107987147B (zh) * 2016-10-26 2024-07-05 牡丹江友搏药业有限责任公司 一种mg53多聚体制备方法及其用途
CN117982625A (zh) * 2017-03-22 2024-05-07 神济昌华(北京)生物科技有限公司 Trim72在预防或治疗als中的用途
CN107629123B (zh) * 2017-09-07 2020-08-25 北京大学 一种抗mg53蛋白的纳米抗体及应用
CN113474011A (zh) * 2018-12-07 2021-10-01 俄亥俄州立创新基金会 促进角膜组织修复的组合物和方法
EP4003388A4 (fr) * 2019-07-25 2024-05-22 Ohio State Innovation Foundation Composition et procédé pour améliorer la performance tissulaire
CN115835877A (zh) 2020-04-14 2023-03-21 俄亥俄州立创新基金会 病毒感染引起的器官衰竭的预防和治疗

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054561A2 (fr) * 2006-07-11 2008-05-08 University Of Medicine And Dentistry Of New Jersey Protéines, acides nucléiques encodant celles-ci et leurs procédés d'utilisation associés
WO2009073808A2 (fr) * 2007-12-04 2009-06-11 University Of Medicine And Dentistry Of New Jersey Compositions et procédés de modulation du recollage de membranes cellulaires

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030224464A1 (en) * 2002-01-31 2003-12-04 Baylor College Of Medicine Secreted caveolin as a marker for prostate cancer
US20110202033A1 (en) * 2006-07-11 2011-08-18 Noah Weisleder Compositions and methods for the treatment and prevention of cardiac ischemic injury
US8058227B2 (en) * 2006-10-03 2011-11-15 Medical University Of South Carolina Method of treating fibrosis in a subject in need thereof comprising administering a composition comprising a CSD
CN101797375B (zh) * 2009-12-02 2013-01-23 北京大学 Mg53蛋白预防和/或治疗心脏缺血/再灌损伤的用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008054561A2 (fr) * 2006-07-11 2008-05-08 University Of Medicine And Dentistry Of New Jersey Protéines, acides nucléiques encodant celles-ci et leurs procédés d'utilisation associés
WO2009073808A2 (fr) * 2007-12-04 2009-06-11 University Of Medicine And Dentistry Of New Jersey Compositions et procédés de modulation du recollage de membranes cellulaires

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CAI CHUANXI ET AL: "MG53 nucleates assembly of cell membrane repair machinery", NATURE CELL BIOLOGY, MACMILLAN MAGAZINES LTD, vol. 11, no. 1, 1 January 2009 (2009-01-01), pages 56 - 64,1, XP002562736, ISSN: 1465-7392, [retrieved on 20081130], DOI: 10.1038/NCB1812 *
JIA YANLIN ET AL: "Treatment of acute lung injury by targeting MG53-mediated cell membrane repair.", NATURE COMMUNICATIONS 2014, vol. 5, 2014, pages 4387, XP002734684, ISSN: 2041-1723 *
LING RONG ET AL: "Panax notoginseng saponins attenuate acute lung injury induced by intestinal ischaemia/reperfusion in rats", RESPIROLOGY, vol. 14, no. 6, 1 August 2009 (2009-08-01), pages 890 - 898, XP055380261, ISSN: 1323-7799, DOI: 10.1111/j.1440-1843.2009.01586.x *

Also Published As

Publication number Publication date
WO2013036610A2 (fr) 2013-03-14
CN104066452A (zh) 2014-09-24
WO2013036610A3 (fr) 2013-05-02
EP2753363A2 (fr) 2014-07-16

Similar Documents

Publication Publication Date Title
LTPA2020006I1 (lt) GDF gaudyklės, skirtos naudoti anemijos gydymui
EP2753363A4 (fr) Compositions comprenant le mg53 et procédés de traitement et de prévention de lésions au niveau des voies respiratoires
EP3386484A4 (fr) Compositions et procédés permettant d'administrer des agents thérapeutiques
EP3273944A4 (fr) Compositions et procédés permettant d'administrer des agents de type biomacromolécule
SI2935303T1 (sl) 4'-fluoro-nukleozidi, 4'-fluoro-nukleotidi in njihovi analogi za zdravljenje HCV
EP2909317A4 (fr) Procédés et compositions de traitement phytosanitaire
IL236054B (en) Compositions and methods for treating Crohn's disease and related conditions and infections
EP2836224A4 (fr) Compositions de microbiota et leurs procédés associés
FR2997271B1 (fr) Dispositif de traitement de la chevelure
EP2854662A4 (fr) Forets chirurgicaux compatibles avec l'irm, et procédés connexes
EP2797661A4 (fr) Dispositif de traitement de la peau
EP2797880A4 (fr) Composés de carbamate de phényle destinés à être utilisés dans la prévention ou le traitement de l'épilepsie
EP2884984A4 (fr) Compositions et procédés thérapeutiques
EP2941267A4 (fr) Procédés et compositions de traitement de la stéatopathie hépatique non alcoolique, de la stéatohépatite et de leurs séquelles
EP2895606A4 (fr) Compositions et procédés de traitement de la sclérose latérale amyotrophique
EP2908865A4 (fr) Procédés de traitement utilisant un adénovirus
EP2678685A4 (fr) Compositions et procédés pour le traitement de profilage de tumeur personnalisé
LTPA2020511I1 (lt) Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
EP2931279A4 (fr) Procédés destinés au traitement du prurit
HK1206266A1 (en) Methods and compositions for the prevention and treatment neuropathy
EP2912033A4 (fr) Compositions et procédés permettant de traiter des affections médicales associées aux strogènes
FR2980207B1 (fr) Composition comprenant du polyamide 66 et du polyamide 610
EP2849798A4 (fr) Compositions de polypeptide-complexe chélaté oligonucléotidique et procédés
LT2683245T (lt) Būdai ir kompozicijos, skirti depresijai gydyti panaudojant ciklobenzapriną
HK1210163A1 (en) Compositions and methods for treating or preventing pneumovirus infection and associated diseases

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20140403

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 14/47 20060101ALI20150127BHEP

Ipc: A61P 9/00 20060101ALI20150127BHEP

Ipc: A61K 31/7088 20060101ALI20150127BHEP

Ipc: A61K 31/105 20060101ALI20150127BHEP

Ipc: A61K 48/00 20060101AFI20150127BHEP

Ipc: A61P 11/00 20060101ALI20150127BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20150209

17Q First examination report despatched

Effective date: 20160614

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20171027